Finance

Lists
SCTX:NASDAQ
Scribe Therapeutics Inc
$34.13
+3.96%
(+1.30) 1D
$34.14
+0.03% (+0.0100)
After hours
Closed: Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SCTX...
Open
$33.90
High
$36.89
Low
$33.90
Avg. vol.
173.90K
Volume
179.58K
52-wk high
$39.60
52-wk low
$17.30
No. of employees
89
Open
$33.90
High
$36.89
Low
$33.90
Avg. vol.
173.90K
Volume
179.58K
52-wk high
$39.60
52-wk low
$17.30
No. of employees
89
News stories
From web sources and news partners
About Scribe Therapeutics Inc
CEO-
Employees89
Founded2017
Headquarters-
SectorBiotechnology
Websitescribetx.com
Analyst ratings
Based on 3 analysts giving stock ratings to SCTX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SCTX in the last 3 months.
Highest
Current $34.13
$60.00 (+75.80%)
Average
$49.00 (+43.57%)
Lowest
$37.00 (+8.41%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Risinger
Leerink Partners
Buy
Initiated
$37.00
+8.4%
08/18/2026
Debjit Chattopadhyay
Guggenheim
Buy
Initiated
$50.00
+46.5%
08/18/2026
Yanan Zhu
Wells Fargo
Buy
Initiated
$60.00
+75.8%
08/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
17.12M
2.23M
Cost of goods sold
15.99M
11.30M
Cost of revenue
15.99M
11.30M
Research and development expenses
-
-
Total research and development expenses
-
-
Selling, general, and admin expenses
6.69M
3.36M
Operating expense
6.69M
3.36M
Total operating expenses
22.68M
14.66M
Operating income
-5.56M
-12.43M
Other non operating income
-
-
EBT including unusual items
-3.74M
-17.12M
EBT excluding unusual items
-5.09M
-12.51M
Income tax expense
-315.00K
228.00K
Effective tax rate
8.42%
-1.33%
Other operating expenses
-
-
Net income
-3.42M
-17.35M
Net profit margin
-20.00%
-776.85%
Earnings per share
-
-
Interest and investment income
1.06M
515.00K
Interest expense
-598.00K
-598.00K
Net interest expenses
465.00K
-83.00K
Depreciation and amortization charges
-
-
EBITDA
-4.81M
-11.79M
Gain or loss from assets sale
-
3.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps